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Summary Chromosome damage in vitro after bleomycin treatment during the late S and G2 phases of the cell cycle was studied in the peripheral lymphocytes of 19 untreated patients with primary testicular tumours and 22 age-matched healthy men with no excess of cancer incidence in the families. The occurrence of
spontaneous chromosome aberrations was not shown to be different in the studied groups. However, in the lymphocytes treated with bleomycin, cancer patients exhibited higher numbers of break events per cell (1.06
versus 0.67, P<0.01) and increased frequency of cells with aberrations (55.0 versus 43.0, P<0.05) than control group. Aberrant cells of cancer patients had more aberrations than cells of the control sample (1.79
versus 1.53, P<0.01). The frequency of chromosome aberrations, often encountered in cancer cells of testicular and other solid tumours, was significantly higher in lymphocytes of patients with testicular cancer (15.0 versus 8.4%, P<0.0001), the long arm of this chromosome being predominantly affected (12.0 versus 6.3%, P<0.0001). These results support the view that a genome disposed to testicular cancer is less effective in the ability to repair non-specific DNA damage in this region, more susceptible to damage, or both.
Testicular cancer (TC) is the most common malignant
tumour in men aged 20-34 years (Senturia, 1987). Ethnic
disposition, early age of onset, high bilateral incidence of
familial TC, some HLA studies and observations in identical
twins suggest a hereditary influence in the aetiology of TC
(Dieckmann et al., 1987).
The existence of several rare chromosome-breakage
syndromes indicates that genetic instability may increase the
probability of mutational events and thus play an important
role in oncogenesis (German, 1983; Hsu, 1987). Since cellular
responses to mutagen action, such as DNA repair and
replication, are thought to be under the control of many
genes in mammalian cells, a gradient of genetic instability
could exist in the population (14su, 1983). Both human
tumour cells and skin fibroblasts or blood lymphocytes
derived from patients with a number of cancer-prone genetic
disorders, when X-irradiated during the G2 phase of the cell
cycle, have more chromatid breaks and gaps during the
postirradiation period than comparable cells from unaffected
individuals (Parshad et al., 1983, 1984; Sanford et al., 1987).
Acquisition of enhanced G2 chromatid radiosensitivity by
normal cells may be an early step in their neoplastic
transformation in culture (Gantt et al., 1987b). Biochemical
and cytogenetic studies indicate that this increased chromatid
damage results from deficient DNA repair (Parshad et al.,
1982; Gantt et al., 1987a; Hsu et al., 1986).
Increased bleomycin-induced chromatid damage in G2
peripheral lymphocytes of some cancer patients has
repeatedly been reported by Hsu et al. (1985, 1987) and
Cherry & Hsu (1983). We used this radiomimetic agent to
expose the late S and G2 lymphocytes of untreated
Caucasian patients with the primary TC.
Materials and methods
Patients and controls
To avoid any diagnostic or therapeutic mutagen exposure
and possible synergic effects of X-irradiation in vivo and
bleomycin treatment in vitro (Alalawi & Chapman, 1977),
heparinised venous blood was obtained from 28 men at the
time of their admission to hospital for testicular enlargement
with suspicion of TC. Only 19 patients with histo-
pathologically verified primary TC were included in the
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study; the rest were either excluded or included in controls if
the patients fitted the criteria used for the selection of the
control group. There were nine patients with seminomas and
10 patients with non-seminomatous tumours. Twenty-two
controls were selected according to sex (only males were
investigated), age (mean age of patients with TC was 29
years, range 21-37, mean age of control group was 26 years,
range 18-33), personal and family history. Only healthy
men with no symptoms suggesting disorder associated with
chromosomal instability were sampled (absence of
neurological and haematological disorders, immune
deficiency, malformations and premature ageing). The
occurrence of tumours in their first and second degree
relatives was up to 0 and 2, respectively. The controls
acknowledged no history of radiation or chemotherapy.
Cultures
Standard whole blood cultures were initiated with
RPMI 1640 medium supplemented with 20% bovine serum,
1% phytohaemagglutinin and antibiotics. All samples were
incubated for 72 h in dark at 37°C. Bleomycin (BLM;
Nippon Kayaku Inc.) was added at a final concentration of
30pgml 1 for the last 5h of culture. Before cell harvest
colcemid treatment was given for 2h. The cells were then
treated in hypotonic solution and fixed in methanol:glacial
acetic acid (3:1, v/v). The slides were Giemsa stained, some
of them were G-banded to determine the exact locations of
break points recorded previously in Giemsa-stained
metaphases.
Scoring aberrations
Chromosome analyses were performed on coded
preparations. Only well spread metaphases with 44-47
chromosomes were evaluated. The spontaneous instability
was analysed by reading 100 metaphases per person, with the
exception of one patient and one man from the control
group. In the samples treated with BLM 96-136 mitotic cells
were examined in each man, except for 32, 52 and 76
metaphases in three patients and 54 and 66 metaphases in
two controls. Gaps or attenuated regions were not
enumerated. The following criteria were used to distinguish
gaps and breaks: (a) when the length of the achromatic
region was equal to or shorter than the width of the
chromatid, the lesion was considered a gap; when the
achromatic segment was longer than the width of the
chromatid, the lesion was regarded as a break (Chatham workshop conference, 1971), (b) if a lesion was a gap
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according to the previous definition and if there was a clear
misalignment of the chromatid distal to centromere it was
counted as a break (Harnden & Klinger, 1985).
For the calculation of aberration rates, chromatid breaks
were considered as a single event and rare chromatid
exchanges or chromosome-type aberrations as two break
events. The frequency of breakage was then expressed as
break events per cell. The pulverised cells (here defined as
cells with more than seven break events) were disregarded in
final computation, but their frequency was recorded. The
break events were assigned to the chromosome arm and
group. The number of breaks, which could not be classified
with certainty, was recorded and was not included in the
distribution analysis. Breaks of chromosomes 1, 2 and 3
were mapped to the bands after G banding procedure. For
statistical analysis we used Student's t test.
Results
Spontaneous instability
The percentage of cells with aberrations and numbers of
chromatid- and chromosome-type aberrations found in the
untreated lymphocytes is shown in Table I. We were unable
to prove a statistical difference in number of the cells with
aberrations between both groups. There were four dicentrics
in the patients with TC, and two dicentrics in controls.
Three of 20 chromatid breaks, which were found in cancer
patients, were located on chromosome 1, two of them on its
long arm. One chromatid break on this chromosome was
recorded in control group.
BLM-induced instability
Table II summarises the frequency of aberrant cells,
pulverised cells, mean number of aberrations per aberrant
cell and the numbers of break events per cell in both groups
after BLM treatment in vitro. Mean frequency of the cells
with aberrations was higher in cancer patients than in the
control group (P<0.05). The proportion of the pulverised
cells was slightly increased in patients with TC, but the
difference was not found to be significant. Aberrant cells of
the cancer patients had more aberrations than the cells of
the control sample (P<0.01).
In both groups a differential response in the number of
break events per cell was documented (Figure 1), ranging
from 0.36 to 2.21 in cancer patients and from 0.14 to 1.29 in
controls, but means differed significantly (P=0.004).
Table I Spontaneous chromosome instability in untreated samples
of both groups
Control Cancer
group patients
Number of persons 22 19
Number of cells analysed 2156 1873
Number of cells with aberrations (%) 29 (1.35) 34 (1.82)
Chromatid aberrations 17 20
chromatid exchanges 0 1
Chromosome aberrations 15 14
dicentrics 2 4
There were no differences in number of break events per
cell between patients with seminomas and non-seminomas,
between the patients with one or more cancer among the
second degree relatives and without family history of cancer,
and there was no correlation with the laterality of TC.
The patients with more advanced TC at diagnosis (nine
patients with stage III and higher; Harmer, 1978) had a
higher number of break events per cell over the low-risk
patients (1.26+0.51 versus 0.88 +0.34), but this difference was
not significant (P=0.09).
We divided each group into two subgroups according to
age (means 25 and 33 years in cancer patients and 23 and 30
years in controls). We did not find a difference in any
parameter studied between younger and older group in both
controls and cancer patients.
The distribution of a total of 1,342 located breaks in
cancer patients and 1,050 breaks in controls on the
chromosomes (Figure 2) revealed increased breakage of
chromosome 1 in cancer patients (15.0% versus 8.4%,
P<0.0001). The decrease in breakage of chromosome
group C was less evident (36.9% versus 45.5%, P<0.001), as
was the increase in the breakage of chromosome group A
(30.6% versus 21.9%, P<0.001) and in the frequency of
chromosome 3 abnormalities (5.6% versus 3.3%, P<0.05).
No statistical difference was found between groups B, D, E,
F, G and chromosome 2.
The distribution of break events on the chromosome arms
showed that the long arm of chromosome 1 was affected
more frequently in TC patients (12.0% versus 6.3%,
P<0.0001) and that it contributes mainly to the increased
chromosome 1 instability (Figure 3). Elevated levels were
found for the short arm of chromosome 3 (P<0.001, F-test)
and a lower frequency for the short and long arms of
chromosome group C (P<0.01, P<0.05, respectively).
The ratio of short-arm break events/long-arm break events
did not reveal a statistical difference between controls and
patients. In both groups a comparable proportion of
unclassified chromatid breaks was recorded (16% in control
group and 15% in cancer patients).
Two and more times repeated break points of
chromosome 1-3 found in individuals of control sample (a)
and cancer group (b) are shown in Figure 4. The most
frequent regions affected were lq2, lq3, and 2q3.
Discussion
Our results showing a differential response to BLM action
further support the hypothesis of a gradient of genetic
instability in population (Hsu, 1983). The broad
interindividual variability to BLM can be explained on
several levels: cellular uptake of the agent, its intracellular
metabolism, direct or indirect action on the DNA and the
cellular response to genetic damage. Only limited
information is available on BLM uptake and its metabolic
inactivation. Increased levels of bleomycin hydrolase, an
aminopeptidase which inactivates BLM, have been reported
in BLM resistant rat hepatoma cells; other studies showed
no difference in hydrolase activity (for review see Sikic,
1986).
The extent to which variability in DNA repair mechanisms
Table II Bleomycin-induced chromosome instability in both groups
Group and Frequency of Frequency of Number of Number of
number of cells with pulverised break events aberrations
cells analysed aberrations (0) cells (%) per cell per aber. cell
Controls (2117)
Mean 43.0 5.8 0.67 1.53
s.d. 18.2 5.4 0.35 0.26
Patients (1876)
Mean 55.0 8.2 1.06 1.79
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contributes to differences in BLM-induced chromosomal
damage is not exactly known. Studies of Saccharomyces
cerevisiae suggest that at least 13 genes may be involved in
the repair of BLM-induced DNA damage. The experiments
with BLM and aphidicolin support a differential repair
capacity among humans (Hsu et al., 1986), possibly
corresponding to the variability found after BLM-induced
chromatid damage. Nevertheless, it seems to be of primary
importance to consider and detect all the factors affecting
G2 BLM-induced chromatid sensitivity, including the
modulators of BLM cytotoxicity (Sikic, 1986) and technical
or laboratory artifacts. Previous radiation exposure of
patients was entirely avoided in our study, but it is not likely
that a low dose in vivo after diagnostic X-ray could exert an
influence on final cell breakage after such a high dose of
1 2 3
Figure 4 The repeated break points of chromosomes 1-3
in individuals of control group (a) and with TC (b).
BLM in vitro. At present, the described test does not seem to
be sufficiently effective in identifying individuals disposed to
TC. To further improve its sensitivity and specificity,
mutagens with different mechanisms of action should be
used (Hsu, 1987).
The abnormalities of chromosome 1 are very frequent in
many, if not all, cancer cells (Atkin, 1986), including
testicular tumours (Wang et al., 1980; DeLozier-Blanchet et
al., 1987). Break points of chromosome 1 are non-random,
being concentrated in the regions of p12, q12, p36 and p22
(Wang et al., 1980). However, the bands most often affected
in the lymphocytes of our cancer patients seemed to be quite
distinct from those found in cancer cells. Our findings of a
more frequently involved chromosome 1 (lq) and 3 (3p) after
non-specific DNA damage indicate that in this region the
genotype disposed to TC may be either more susceptible to
damage or less effective in its ability to repair it (for review
see Bohr et al., 1987). Combination treatment with BLM
and aphidicolin (Hsu et al., 1986) indicates that under given
conditions, BLM induces approximately the same number of
DNA lesions. Furthermore, the relationship between a
disposition to the germ-cell gonadal tumours and DNA
repair is of particular interest with respect to the
maintenance of DNA in the germ line. It is conceivable that
in the lymphocytes of patients with other solid tumours a
similar increase in chromosome 1 breakage could be found.
The possible relationship between the fragile site at 3p14 and
the increased breakage of 3p in our cancer patients remains
to be elucidated.
Isochromosome i(12p) is considered a possible specific
marker of gonadal germ cell tumours (Atkin & Baker, 1983;
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DeLozier-Blanchet et al., 1987). We did not determine an
involvement of chromosome 12 in breakage, but we observed
slightly more frequent chromosome instability of groupF,
corresponding in size to this isochromosome.
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